{"id":432072,"title":"Notice of intent to amend: Prescription Drug List (PDL): Epinephrine (Topical Solution) - Canada.ca","sourceCode":"hc","sourceName":"Health Canada","language":"en","captureDate":"2026-01-02","captureTimestamp":"2026-01-02T07:10:56.952000+00:00","jobId":6,"originalUrl":"https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/prescription-drug-list/notices-changes/intent-amend-epinephrine-topical-solution.html","snippet":"Notice of intent to amend: Prescription Drug List (PDL): Epinephrine (Topical Solution) June 4, 2021 Our file number: 21-110492-852 The purpose of this Notice of Intent to Amend is to announce that Health Canada will add Epinephrine topical solution for hemostasis when sold at a…","rawSnapshotUrl":"/api/snapshots/raw/432072","browseUrl":"https://replay.healtharchive.ca/job-6/20260102071056/https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/prescription-drug-list/notices-changes/intent-amend-epinephrine-topical-solution.html#ha_snapshot=432072","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}